Skip to main content
Clinical Trials/NCT02160639
NCT02160639
Unknown
Not Applicable

Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support

American Association of Diabetes Educators4 sites in 1 country449 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus Type 2
Sponsor
American Association of Diabetes Educators
Enrollment
449
Locations
4
Primary Endpoint
Change from baseline HbA1c at 3, 9, 15, and 27 months
Last Updated
9 years ago

Overview

Brief Summary

Improving diabetes social support is associated with health improvement benefits. This study is a prospective randomized controlled trial comparing the effects of telephone-based diabetes self-management support (DSMS) compared with usual care, which includes diabetes self-management education (DSME), during a 1-year period. It will determine whether this specific model for providing on-going support to people with diabetes will better enable them to maintain the engagement in self-care behaviors, clinical improvements and diabetes-specific knowledge gained during the course of diabetes self-management education.

Detailed Description

Diabetes self management support is telephonic and will be provided by health navigators at a central call center

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
May 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
American Association of Diabetes Educators
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English or Spanish speaking
  • Diagnosis of type 2 diabetes mellitus
  • HbA1c \> 8
  • Have not completed a diabetes self management education program in the past year

Exclusion Criteria

  • Current engagement in cancer treatment
  • Diagnosis of end-stage renal disease
  • Receiving immunosuppressant therapy following transplant
  • Diagnosis of serious mental illness
  • Undergoing systemic treatment with prednisone

Outcomes

Primary Outcomes

Change from baseline HbA1c at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

HbA1c assessment

Change from baseline blood pressure at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

blood pressure assessments

Change from baseline cholesterol at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

cholesterol assessments

Change from baseline BMI at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

body mass index (BMI) assessments

Change from baseline weight at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

weight assessments

Change from baseline fasting glucose at 3, 9, 15, and 27 months

Time Frame: 0, 3, 9, 15, and 27 months

fasting glucose assessments

Secondary Outcomes

  • Change from baseline patient credential at 3, 9, 15, and 27 months(0, 3, 9, 15, and 27 months)
  • Change from baseline depression at 3, 9, 15, and 27 months(0, 3, 9, 15, and 27 months)
  • Change from baseline food security at 3, 9, 15, and 27 months(0, 3, 9, 15, and 27 months)

Study Sites (4)

Loading locations...

Similar Trials